The choice, he explained, of which compounds would enter NIAID’s clinical trial pipeline was made, not by public agreement, but by a panel of “independent scientists.” Dr. Fauci did not mention that virtually all the members of his “independent panel” were pharmaceutical PIs, with ties to NIAID and Burroughs Wellcome.
